CN108872607B - 一种α2-巨球蛋白(α2-MG)检测试剂盒 - Google Patents
一种α2-巨球蛋白(α2-MG)检测试剂盒 Download PDFInfo
- Publication number
- CN108872607B CN108872607B CN201810924626.XA CN201810924626A CN108872607B CN 108872607 B CN108872607 B CN 108872607B CN 201810924626 A CN201810924626 A CN 201810924626A CN 108872607 B CN108872607 B CN 108872607B
- Authority
- CN
- China
- Prior art keywords
- macroglobulin
- reagent
- buffer solution
- detection
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 title claims abstract description 44
- 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 title claims abstract description 44
- 238000001514 detection method Methods 0.000 title claims abstract description 44
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 79
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000004816 latex Substances 0.000 claims abstract description 31
- 229920000126 latex Polymers 0.000 claims abstract description 31
- 239000002245 particle Substances 0.000 claims abstract description 25
- CAZBGNGNIZEMPG-UHFFFAOYSA-N 4,5-dihydro-1h-imidazol-1-ium;acetate Chemical compound CC([O-])=O.C1CN=C[NH2+]1 CAZBGNGNIZEMPG-UHFFFAOYSA-N 0.000 claims abstract description 22
- VDIVMEQCLDUWBV-UHFFFAOYSA-N C(CCCCCCCCCC)C(C(=O)O)[Na] Chemical compound C(CCCCCCCCCC)C(C(=O)O)[Na] VDIVMEQCLDUWBV-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000003755 preservative agent Substances 0.000 claims abstract description 18
- 230000002335 preservative effect Effects 0.000 claims abstract description 18
- 239000007853 buffer solution Substances 0.000 claims abstract description 17
- 241000283707 Capra Species 0.000 claims abstract description 15
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000008118 PEG 6000 Substances 0.000 claims abstract description 13
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 claims abstract description 13
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 13
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 13
- 235000011187 glycerol Nutrition 0.000 claims abstract description 13
- 239000005018 casein Substances 0.000 claims abstract description 9
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000021240 caseins Nutrition 0.000 claims abstract description 9
- 108010010803 Gelatin Proteins 0.000 claims abstract description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 8
- 229920000159 gelatin Polymers 0.000 claims abstract description 8
- 239000008273 gelatin Substances 0.000 claims abstract description 8
- 235000019322 gelatine Nutrition 0.000 claims abstract description 8
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 8
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 15
- XNRNJIIJLOFJEK-UHFFFAOYSA-N sodium;1-oxidopyridine-2-thione Chemical group [Na+].[O-]N1C=CC=CC1=S XNRNJIIJLOFJEK-UHFFFAOYSA-N 0.000 claims description 12
- 238000003149 assay kit Methods 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 17
- 239000000872 buffer Substances 0.000 description 12
- 238000003908 quality control method Methods 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 239000003381 stabilizer Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000851 acute glomerulonephritis Toxicity 0.000 description 1
- 201000003229 acute pancreatitis Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000021523 carboxylation Effects 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810924626.XA CN108872607B (zh) | 2018-08-14 | 2018-08-14 | 一种α2-巨球蛋白(α2-MG)检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810924626.XA CN108872607B (zh) | 2018-08-14 | 2018-08-14 | 一种α2-巨球蛋白(α2-MG)检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108872607A CN108872607A (zh) | 2018-11-23 |
CN108872607B true CN108872607B (zh) | 2020-04-28 |
Family
ID=64319056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810924626.XA Active CN108872607B (zh) | 2018-08-14 | 2018-08-14 | 一种α2-巨球蛋白(α2-MG)检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108872607B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112285341A (zh) * | 2019-07-25 | 2021-01-29 | 苏州普瑞斯生物科技有限公司 | 一种α2-巨球蛋白检测试剂盒及其制备方法 |
CN112198319A (zh) * | 2020-10-23 | 2021-01-08 | 安徽伊普诺康生物技术股份有限公司 | 一种稳定性增强的人免疫球蛋白g4试剂盒 |
CN113740541B (zh) * | 2021-09-22 | 2022-09-16 | 长春晨裕伽康生物科技有限公司 | 一种α2巨球蛋白快速检测试剂盒及检测方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102901810B (zh) * | 2012-10-09 | 2014-08-27 | 北京九强生物技术股份有限公司 | 包被有前列腺特异性抗原抗体的胶乳颗粒的制备方法及psa胶乳增强免疫比浊法检测试剂盒 |
CN106996978A (zh) * | 2017-03-01 | 2017-08-01 | 北京九强生物技术股份有限公司 | α2巨球蛋白检测试剂盒及其制备方法 |
CN107015004A (zh) * | 2017-03-21 | 2017-08-04 | 深圳市汇松科技发展有限公司 | 一种血清淀粉样蛋白a测定试剂盒及其制备方法 |
-
2018
- 2018-08-14 CN CN201810924626.XA patent/CN108872607B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102901810B (zh) * | 2012-10-09 | 2014-08-27 | 北京九强生物技术股份有限公司 | 包被有前列腺特异性抗原抗体的胶乳颗粒的制备方法及psa胶乳增强免疫比浊法检测试剂盒 |
CN106996978A (zh) * | 2017-03-01 | 2017-08-01 | 北京九强生物技术股份有限公司 | α2巨球蛋白检测试剂盒及其制备方法 |
CN107015004A (zh) * | 2017-03-21 | 2017-08-04 | 深圳市汇松科技发展有限公司 | 一种血清淀粉样蛋白a测定试剂盒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108872607A (zh) | 2018-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108872607B (zh) | 一种α2-巨球蛋白(α2-MG)检测试剂盒 | |
CN108872606B (zh) | 一种高度稳定、灵敏的结合珠蛋白(hp)检测试剂盒 | |
CN101377492A (zh) | 胱抑素c测定试剂盒 | |
CN109725160B (zh) | 一种降钙素原(pct)检测试剂盒 | |
CN102621332A (zh) | 基于胶乳粒子包被视黄醇结合蛋白检测试剂盒 | |
CN103645323A (zh) | 一种胱抑素c检测试剂盒及其制备方法 | |
CN102662064A (zh) | 检测中性粒细胞明胶酶相关脂质运载蛋白的免疫比浊试剂盒及其制备方法 | |
CN103454193A (zh) | 检测脂蛋白(a)的免疫比浊试剂盒及其制备方法 | |
CN109870570A (zh) | 一种检测猴il-18的酶联免疫试剂盒 | |
CN111307789A (zh) | 一种叶酸检测试剂盒及检测方法 | |
CN109613257B (zh) | 一种转铁蛋白(trf)检测试剂盒 | |
CN111781372A (zh) | 一种基于混合抗体的α1-AT免疫比浊法检测试剂盒及其制备使用方法 | |
CN112763725B (zh) | 一种胶乳比浊法测定c反蛋白检测试剂的制备及应用 | |
CN108490187B (zh) | 一种稳定、灵敏的四型胶原蛋白(iv-c)检测试剂 | |
CN106526198A (zh) | 一种组合定向剂优化胶乳偶联抗体检测前白蛋白(pa)的方法 | |
CN103743912A (zh) | 一种b因子测定试剂盒及其制备方法 | |
CN103529221A (zh) | 一种用于检测血清中酸性糖蛋白含量的试剂盒 | |
CN106841596B (zh) | 一种测定人血清中甘胆酸的试剂盒及其应用方法 | |
CN114200129B (zh) | 组织金属蛋白酶抑制剂-2胶乳免疫比浊法血尿同检试剂盒 | |
CN108362892B (zh) | 一种降钙素原胶体金免疫比浊法检测试剂 | |
CN114295840B (zh) | 一种高灵敏度定量测定脂联素的试剂盒及其制备方法 | |
CN114112957B (zh) | 一种脂联素测定试剂盒及其应用 | |
CN110407934A (zh) | 抗人白蛋白混合抗体及测定试剂盒 | |
CN115561450A (zh) | 用于检测触珠蛋白含量的试剂盒 | |
CN108169493A (zh) | 一种血清淀粉样蛋白a检测试剂盒及其制备、使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: one kind a 2-Macroglobulin( a 2-MG) detection kit Effective date of registration: 20230628 Granted publication date: 20200428 Pledgee: Bank of Communications Ltd. Shandong branch Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980045843 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20200428 Pledgee: Bank of Communications Ltd. Shandong branch Pledgor: BIOBASE BIODUSTRY (SHANDONG) Co.,Ltd. Registration number: Y2023980045843 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |